Add like
Add dislike
Add to saved papers

Application of Brachypodium genotypes to the analysis of type II resistance to Fusarium head blight (FHB).

The resistance to Fusarium head blight (FHB) in wheat is mainly via the restrain of fungal expansion through spike rachis (type II resistance). In order to unravel the resistance mechanisms, Brachypodium distachyon 21 (Bd21), a monocotyledonous model plant, was previously proved to interact with F. graminearum, while the disease development in spike still needs to be explored in detail. Herein, it is found that the fungal spores mainly germinate on pistil of Bd21, then the hyphae rapidly extend to the bottom of floret and enter spike rachis, similar with the infection progress in wheat. However, structural difference of spike rachis was found between Brachypodium and wheat. It was found that the spread of the fungus through the rachis node of inoculated spikelets is an important index for the evaluation of type II FHB resistance in Brachypodium under optimal conditions at 28 °C and 50%-70% humidity. To verify the feasibility of this strategy, the transcription factor TaTGA2 was overexpressed in Bd21, and transgenic plants were found to show improved resistance to F. graminearum in both spikes and detached leaves, which was further supported by the increased disease severity when silencing TaTGA2 in the wheat cultivar "Sumai 3" or in tilling "Kronos" mutants. Except for Bd21, another 49 Brachypodium germplasms were further screened for FHB resistance, and three moderately susceptible germplasms, namely, PI 317418, W6-39284, and PI 254868, feasible for transformation, were determined to be better hosts than Bd21 when evaluating heterologous genes that positively regulate FHB resistance. The present study also observed variations in the levels of FHB resistance between coleoptiles and spikes or transgenic plants and natural germplasms.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app